Back to Trials
NCT06858449NARecruiting

Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Start Date

1/2/2025

Completion Date

3/1/2027

Summary

In this study, the investigators hypothesize that a high dose of post-workout protein nutrition regimen focused on food quality and an observed exercise regimen utilizing high-load resistance training initiated during or after cancer treatment will improve body composition and functional capacity.

Eligibility Criteria

Age Range: 20 years to 89 years

Inclusion Criteria: 1. Age 20-89 years 2. Women with a biopsy proven diagnosis of invasive carcinoma of the breast. 3. Women must undergo neoadjuvant chemotherapy for breast cancer treatment prior to surgery 4. Must be able to read and understand English and consent for themselves. Exclusion Criteria: 1. Inability to get up and down off the ground or squat body weight 2. Inability to safely engage in group exercise sessions as deemed by study PI 3. Severe arthritic, joint, cardiovascular, musculoskeletal, or any other condition deemed by PI to be unsafe to engage in resistance training 4. Lactose intolerance 5. Cow's milk or whey protein allergy 6. Pregnant women 7. Males

Interventions

DIETARY_SUPPLEMENT

Whey protein (20 grams)

DIETARY_SUPPLEMENT

Whey protein (60 grams)

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

CancerBreast Cancer

Locations

Allegheny General Hospital

Pittsburgh, Pennsylvania 15212

United States